These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Are paranoid schizophrenics biologically different from other schizophrenics? Potkin SG, Cannon HE, Murphy DL, Wyatt RJ. N Engl J Med; 1978 Jan 12; 298(2):61-6. PubMed ID: 619236 [Abstract] [Full Text] [Related]
27. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs. Kemali D, Maj M, Ariano MG, Salvati A. Encephale; 1985 Jan 12; 11(1):31-4. PubMed ID: 2859981 [Abstract] [Full Text] [Related]
28. On the relation between platelet monoamine oxidase activity and the growth hormone response in psychosis. Hitzemann R, Hirschowitz J, Zemlan F, Hitzemann B, Garver D. Biol Psychiatry; 1983 Dec 12; 18(12):1503-7. PubMed ID: 6661478 [No Abstract] [Full Text] [Related]
36. Platelet MAO activity and family history of schizophrenia. Duncavage M, Luchins DJ, Meltzer HY. Psychiatry Res; 1982 Aug 25; 7(1):47-51. PubMed ID: 6957899 [Abstract] [Full Text] [Related]
37. Schizophrenia and platelet monoamine oxidase: research strategies. Buchsbaum MS, Coursey RD, Murphy DL. Schizophr Bull; 1980 Aug 25; 6(2):375-84. PubMed ID: 6103578 [Abstract] [Full Text] [Related]
38. Reduced MAO activity in platelets and lymphocytes of chronic schizophrenics. Sullivan JL, Cavenar JO, Stanfield CN, Hammett EB. Am J Psychiatry; 1978 May 25; 135(5):597-8. PubMed ID: 645956 [No Abstract] [Full Text] [Related]